S
DXCM icon

SignatureFD’s DexCom DXCM Stock Holding History

SignatureFD’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294K Buy
4,681
+528
+13% +$36.8K ﹤0.01% 820
2025
Q4 		$276K Sell
4,153
-1,196
-22% -$77.3K ﹤0.01% 818
2025
Q3 		$360K Sell
5,349
-485
-8% -$38.4K 0.01% 704
2025
Q2 		$509K Buy
5,834
+266
+5% +$20.9K 0.01% 565
2025
Q1 		$380K Sell
5,568
-993
-15% -$81K 0.01% 625
2024
Q4 		$510K Buy
6,561
+1,526
+30% +$113K 0.01% 518
2024
Q3 		$338K Sell
5,035
-4,606
-48% -$378K 0.01% 657
2024
Q2 		$1.09M Sell
9,641
-128
-1% -$16.2K 0.02% 281
2024
Q1 		$1.35M Buy
9,769
+249
+3% +$31.3K 0.03% 240
2023
Q4 		$1.18M Buy
9,520
+740
+8% +$75.6K 0.03% 247
2023
Q3 		$819K Sell
8,780
-563
-6% -$63.5K 0.02% 300
2023
Q2 		$1.2M Buy
9,343
+65
+0.7% +$7.86K 0.03% 218
2023
Q1 		$1.08M Buy
9,278
+160
+2% +$17.9K 0.03% 225
2022
Q4 		$1.03M Buy
9,118
+966
+12% +$106K 0.03% 224
2022
Q3 		$657K Buy
8,152
+2,881
+55% +$244K 0.02% 296
2022
Q2 		$393K Sell
5,271
-1,125
-18% -$103K 0.01% 440
2022
Q1 		$818K Sell
6,396
-164
-3% -$17.9K 0.02% 260
2021
Q4 		$881K Buy
6,560
+468
+8% +$67.2K 0.03% 238
2021
Q3 		$833K Buy
6,092
+864
+17% +$109K 0.03% 230
2021
Q2 		$558K Buy
5,228
+444
+9% +$42.6K 0.02% 324
2021
Q1 		$430K Sell
4,784
-564
-11% -$52.9K 0.02% 349
2020
Q4 		$494K Sell
5,348
-944
-15% -$84.3K 0.02% 278
2020
Q3 		$648K Sell
6,292
-1,208
-16% -$126K 0.03% 187
2020
Q2 		$760K Buy
7,500
+1,352
+22% +$121K 0.05% 151
2020
Q1 		$414K Buy
6,148
+1,768
+40% +$110K 0.04% 225
2019
Q4 		$240K Buy
4,380
+112
+3% +$5.31K 0.02% 410
2019
Q3 		$159K Buy
4,268
+212
+5% +$8.24K 0.01% 483
2019
Q2 		$152K Sell
4,056
-44
-1% -$1.38K 0.01% 478
2019
Q1 		$122K Sell
4,100
-1,600
-28% -$56.2K 0.01% 553
2018
Q4 		$171K Buy
5,700
+44
+0.8% +$1.4K 0.02% 413
2018
Q3 		$202K Hold
5,656
– – 0.02% 412
2018
Q2 		$134K Hold
5,656
– – 0.01% 509
2018
Q1 		$105K Buy
+5,656
New +$83.6K 0.01% 515
2016
Q4 		– Sell
-5,708
Closed -$125K – 507
2016
Q3 		$125K Buy
5,708
+352
+7% +$7.83K 0.02% 309
2016
Q2 		$106K Hold
5,356
– – 0.02% 290
2016
Q1 		$91K Sell
5,356
-32
-0.6% -$535 0.02% 295
2015
Q4 		$110K Sell
5,388
-16
-0.3% -$333 0.02% 226
2015
Q3 		$116K Sell
5,404
-292
-5% -$6.51K 0.03% 191
2015
Q2 		$114K Hold
5,696
– – 0.02% 205
2015
Q1 		$89K Buy
5,696
+96
+2% +$1.45K 0.02% 227
2014
Q4 		$77K Buy
5,600
+1,600
+40% +$19.6K 0.02% 239
2014
Q3 		$40K Hold
4,000
– – 0.01% 276
2014
Q2 		$40K Hold
4,000
– – 0.01% 275
2014
Q1 		$41K Hold
4,000
– – 0.02% 224
2013
Q4 		$35K Hold
4,000
– – 0.01% 263
2013
Q3 		$28K Buy
+4,000
New +$25.3K 0.01% 287

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SignatureFD's DXCM Position: Q1 2026 in Review

SignatureFD increased its DexCom (DXCM) stake by 13% in Q1 2026, buying an estimated $36.8K and bringing the position to 4,681 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

SignatureFD first reported a position in DXCM in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.35M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • SignatureFD held 4,681 shares of DexCom worth $294K as of Q1 2026.
  • SignatureFD bought 528 DexCom shares in Q1 2026, an estimated $36.8K.
  • DexCom made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #820 holding.
  • SignatureFD first reported a position in DexCom in Q3 2013 and has held it in 46 quarters since.
  • SignatureFD's DexCom position peaked at $1.35M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.